Research team develops nanoparticle-based sonodynamic therapy for H. pylori infection

Helicobacter pylori (H. pylori) is a common pathogen that can be transmitted from person to person. Long-term H. pylori infection has been recognized as a Class I human carcinogen. Currently, the standard clinical treatments for H. pylori infection (i.e., triple and quadruple therapy) rely on oral antibiotics to clear H. pylori from the stomach.